Abstract-Various coronary physiological measurements can be made in the cardiac catheterization laboratory using sensor-tipped guidewires; they include the measurement of poststenotic absolute coronary flow reserve, the relative coronary flow reserve, and the pressure-derived fractional flow reserve of the myocardium. Ambiguity regarding abnormal microcirculation has been reduced or eliminated with measurements of relative coronary flow reserve and fractional flow reserve. The role of microvascular flow impairment can be separately determined with coronary flow velocity reserve measurements. In addition to lesion assessment before and after intervention, Key Words: physiology Ⅲ catheterization Ⅲ heart Ⅲ coronary blood flow A n appreciation of coronary physiology is an integral part of clinical decision-making for cardiologists treating patients with coronary artery disease. The pioneering research efforts of Dr Lance Gould, who explored the relationship between the anatomic severity of a stenosis and its flow resistance, 1,2 have been transferred to clinical practice. 3, 4 Within the last few years, technology has advanced such that, in patients undergoing coronary angiography, the influence of a coronary stenosis on the distal arterial pressure-flow relationship can now be easily and safely determined with sensor-tipped angioplasty guidewires that measure the poststenotic absolute coronary flow velocity reserve (CVR), the relative CVR (rCVR), and the pressure-derived fractional flow reserve of the myocardium (FFR). However, theoretical concerns regarding the translation of basic physiology from experimental animal models has given some clinicians pause in applying the available techniques for patient care. 5, 6 This review will discuss the current concepts, methods, and clinical outcomes of these techniques and provide practical insights for patient management.
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Before applying these physiological measurements, a brief review of several fundamental principles is in order. Recall that when an epicardial stenosis produces an increased resistance to flow, the distant microvascular resistance vessels dilate to maintain regional basal flow at a level appropriate for concurrent myocardial oxygen demand. The increased dilation reduces the potential maximal flow reserve available. Because the distal microcirculation has compensated for the potential reduction in regional flow, the resting poststenotic epicardial conduit blood flow, depending on the severity of the stenosis, may be somewhat diminished; however, this epicardial flow usually satisfactorily maintains myocardial function and metabolism. Under these conditions, any increase in myocardial oxygen demand or other hyperemic stimuli now results in a smaller increment in poststenotic flow relative to the coronary flow increase that would be elicited in the same (or another) myocardial region without a stenosis (ie, diminished CVR and rCVR).
A significant stenosis also produces distal artery pressure loss (ie, a translesional pressure gradient) because of a loss of kinetic (flow) energy to viscous friction, turbulence, and flow separation. The reduction of the distal distending arterial pressure results in a pressure differential or gradient between the driving aortic pressure and the poststenotic coronary pressure. The degree of pressure loss is directly related to the flow rate as described by the curvilinear pressure-flow relationship of the particular lesion resistance (Figure 1 ). 1,2
Beyond Coronary Pressure Gradients
For clinical coronary artery lesion assessment, resting pressure gradients measured during the early experience with coronary angioplasty were unsatisfactory because of (1) inadequate devices (ie, balloon catheters), (2) data being used in an incompletely understood manner (ie, only at rest and not during maximal blood flow), 7, 8 and (3) a weak correlation to ischemic testing and clinical outcomes. 7,9,10 Pijls et al [11] [12] [13] demonstrated that the hyperemic absolute distal coronary pressure, but not the resting pressure gradient, is related to the ischemic potential of a stenosis. Moreover, they derived a new concept of a pressure-derived estimate of coronary blood flow, the FFR. The FFR is the fraction of maximal coronary blood flow that goes through the stenotic vessel, expressed as a percentage of blood flow through the same artery in the theoretical absence of the stenosis. The FFR, calculated as the ratio of the absolute distal coronary and aortic pressures measured during maximal hyperemia (ie, when minimal resistance is present across both the epicardial and microvascular beds), reflects myocardial perfusion (both antegrade and collateral) rather than merely trans-stenotic pressure loss. Unlike CVR, FFR is independent of driving pressure, heart rate, systemic blood pressure, and the status of the microcirculation, 14 and it reflects both antegrade and collateral blood flow. The normal value for FFR is 1 for each patient, coronary artery, myocardial distribution, and microcirculatory status.
Lesion-Specific Physiological Measurements
A normal absolute CVR, the ratio of hyperemic to basal mean flow (velocity), indicates a normal 2-component system, with a patent epicardial conduit supplying a normal myocardial bed. In the absence of epicardial conduit obstruction, the CVR may be abnormal when the microvascular circulation is compromised by left ventricular hypertrophy, chronic or acute ischemia, diabetes mellitus, or other diseased rheological conditions. 15, 16 An abnormal CVR cannot differentiate which of the 2 components is responsible for flow impairment. In this setting, an additional measurement of CVR in an adjacent, normal vessel as a reference value (CVR reference ) can confirm the significance of the coronary lesion and compute the rCVR (rCVRϭCVR target /CVR reference ). 17 Assuming that systemic hemodynamic and microcirculatory abnormalities affect the different regions of the myocardium to the same degree, the rCVR should nullify the influence of the variables and provide an enhanced discrimination of flow impairment due to a stenosis. 17 The CVR in angiographically normal vessels from adult patients with coronary artery disease risk factors is 2.7Ϯ0.6 18 and, in most studies, it seems to have little regional variation (Ͻ15%) in both cardiac transplant patients and patients with chest pain syndromes. The normal value of the rCVR is Ͼ0.8. 18, 19 Unlike absolute CVR, both rCVR and the FFR are considered more lesion-specific physiological measurements. Baumgart et al 19 compared FFR to both absolute CVR and rCVR in 24 vessels that had stenoses ranging from 40% to 95% (average, 74Ϯ15%). Target and reference vessel CVR were 2.1Ϯ0.5 and 2.6Ϯ0.7, respectively; the rCVR was 0.82Ϯ0.13 (range, 0.53 to 1.0), and the FFR was 0.81Ϯ0.15 (range, 0.49 to 0.99). FFR and rCVR, but not CVR, showed a strong curvilinear relationship to percent area stenosis (rϭ0.89 and rϭ0.79; PϽ0.0001), with a close linear relationship between FFR and rCVR (rϭ0.95; PϽ0.0001) that supported the lesion-specific nature of these 2 measurements.
Limitations of Coronary Flow Reserve
Microcirculatory impairment is the major limitation in assessing a stenosis using absolute CVR; this issue is addressed by rCVR or FFR. In patients in whom the target vessel supplies an area of myocardial infarction, neither CVR nor rCVR can confidently identify flow impairment due solely to a stenosis because the assumption that the microvascular circulation is uniform no longer applies. In patients with 3-vessel coronary disease, no suitable reference vessel may exist, which compromises the use of rCVR. A lesion in these situations may be best assessed by FFR.
Advantages and Limitations of FFR
Although FFR seems to be independent of microvascular responses or changing hemodynamics, 14 which is a significant advantage over CVR, the magnitude of the flow increase during maximal vasodilatation still influences FFR. 11, 12 A limited increase in flow across a stenosis could minimize the true FFR value. However, because the FFR reflects the extent to which the epicardial resistance reduces myocardial perfusion, it can be argued that in the setting of microvascular disease, a normal FFR indicates that the conduit resistance (ie, the stenosis in question) is not a major contributing factor to perfusion impairment and that the enlargement of such a conduit obstruction would not restore normal perfusion. In such diagnostic dilemmas, FFR and Doppler velocimetry are complementary; they describe the physiology of both the epicardial stenosis and the microvascular disease (if present) as potential contributors to inducible myocardial ischemia.
It should be recognized that the normal threshold of FFR (Ͻ0.75) for ischemia was derived from a selected, stable patient population with single-vessel coronary disease and normal left ventricular function. The data are limited for patients with microvascular disease, acute or remote myocar- dial infarction, and unstable angina. Caution should be applied in extending the current physiological criteria to such patients. The advantages and limitations of the 3 physiological measurements for patients with coronary artery disease are summarized in Table 1 .
Concerns Regarding the Practical Application of Physiological Measurements in Patients
Although the discussed techniques are particularly well suited for both diagnostic and interventional therapy, several investigators have expressed concerns over the potential technical and biological limitations of in-laboratory physiological measurements. 5, 6, 20 Technical or operator-related artifacts, such as variability in Doppler velocity envelopes, pressure signal drift, or malalignment, should be avoided as previously described. 11, 18 Similarly, the cross-sectional area of a sensor guidewire (0.16 mm 2 ) is negligible relative to all but the most critical stenoses. 21 Although a potentially false-negative physiological evaluation could occur in the setting of transient vasoconstriction of a stenotic lesion or the microcirculation, episodic or dynamic ischemia that is not detectable by measurements at the time of investigation can be attenuated or eliminated by concomitant antianginal therapies. Dynamic stenotic resistance with inducible variations may occur both at rest and during maximal hyperemia 22 in response to a variety of intrinsic and extrinsic stimuli. [22] [23] [24] A false-negative CVR could also be obtained if the ischemic myocardium was confined to only a small region, such as the subendocardium or papillary muscle. Like any diagnostic modality, the results must be considered in the dynamic course of the clinical presentation.
The pharmacological hyperemic agents used to identify impaired flow are thought to be equivalent to exercise stress hyperemia. These agents may be unsatisfactory in rare individuals with increased susceptibility to myocardial ischemia that is not reflected solely in the flow-limiting nature of the stenosis. Figure 2 illustrates the physiological assessment of difficult intermediate coronary stenoses.
Clinical Validation
Although some of the theoretical concerns regarding the limitations of direct physiological measurements cannot be completely satisfied, the clinical validation and outcomes strongly support the practical value of in-laboratory measurements. Many of the above-noted concerns and potential complexities of using coronary physiological measurements for clinical decisions arise from the failure of suitable experimental animal and clinical studies to define unambiguous criteria of myocardial ischemia. In patients, the valida- tion of coronary physiological criteria has been established by population correlations with clinically accepted norms of several types of ischemic stress provocation. 13, [25] [26] [27] [28] [29] [30] [31] [32] [33] For poststenotic coronary flow velocity reserve, several single-center studies 26 -28 and one multicenter trial 29 have reported strong correlations with myocardial stress perfusion; one study using 2D echocardiographic stress imaging 32 reported correlations with an abnormal distal CVRϽ2.0, which corresponded to reversible myocardial perfusion imaging defects (and stress-induced wall motion). These studies had high sensitivity (86% to 92%), specificity (89% to 100%), predictive accuracy (89% to 96%), and positive and negative predictive values (94% to 100% and 77% to 95%, respectively; Table 2 ).
Similarly, for FFR, Pijls et al 13 and De Bruyne et al 25 also report high correlations for identifying reversible ischemia with an FFRϽ0.75. In the study by Pijls et al, 13 sensitivity was 88%, specificity was 100%, and positive and negative predictive values were 100% and 88%, respectively; the study had a predictive accuracy of 93%.
The clinical outcomes of deferring coronary intervention for intermediate stenoses with normal physiology that are now reported in Ն5 studies 13,34 -38 are remarkably consistent, with clinical event rates of Ͻ10% over a 2-year follow-up period. In these studies, because of clinical requirements, it was not feasible to defer treatment in symptomatic patients with abnormal translesional physiology. It is highly likely that these individuals would, at the least, continue to be symptomatic or have higher event rates. It should also be noted that although the safety of deferring angioplasty on the basis of a normal CVR can be demonstrated, some patients with deferred procedures had a lower rate of angina-free follow-up compared with patients who underwent angioplasty. 35 Nonetheless, when physiologically normal, the functional and clinical impact of medically-treated, angiographically intermediately-severe stenoses is associated with an excellent clinical outcome. Physiological criteria support decisions to defer intervention in such situations while continuing medical therapy for endothelial dysfunction, hypertension, hyperlipidemia, and episodic coronary vasoconstriction.
Comparison With Intravascular Ultrasound Imaging
Despite sophisticated quantitative modeling, neither intravascular ultrasound imaging (IVUS) nor coronary angiography can predict the resistance to flow through intermediatelynarrowed epicardial coronary conduits. This is due to factors such as stenosis length, entrance and exit angles, coefficients of viscous friction and separation, and the status of the distal microvascular bed. Moses et al 39 studied 42 patients with coronary stenoses ranging from 18% to 95%; they reported that in those patients with a CVRϽ1.8, the IVUS reference segment area, IVUS lumen area, and angiographic percent diameter stenosis were higher (17 41 demonstrated that an IVUS minimal lumen area Ͻ3.0 mm 2 and an area stenosis Ͻ60% had 100% predictive accuracy for a FFRϽ0.75. Despite a precise dimensional measurement, a single tomographic IVUS image (except in the extremes) correlated weakly with measured coronary physiological responses.
Conversely, FFR may be equivalent to IVUS in the assessment of optimal stent deployment. Hanekamp et al 42 found IVUS and FFRϾ0.94 had 91% concordance in the identification of optimal stent apposition and deployment. 
Physiological End Points for Coronary Interventions
It is now known that the failure of coronary blood flow reserve to improve after balloon angioplasty in Ն50% of patients 43, 44 is principally due to 2 mechanisms: impairment of microcirculatory responses (either preexisting or induced after vessel trauma) and/or inadequate epicardial lumen expansion not readily appreciated by angiography. Microvascular circulatory impairment, which was initially thought to be the predominant mechanism, is likely the less common condition because stenting, compared with angioplasty alone, achieves a larger and more uniformly cylindrical lumen by IVUS and normalizes CVR in most (Ϸ80%) patients. 45 In the 20% of patients with a poststent CVRϽ2.0, rCVR or FFR may be useful in identifying persistent conduit abnormalities. A typical example of pressure and flow measurements after coronary angioplasty and stenting is illustrated in Figure 3 . A physiological end point associated with improved late outcomes after coronary angioplasty was identified in the Doppler End point Balloon Angioplasty Trial, Europe (DE-BATE I), trial. 46 A CVRϾ2.5 coupled with an acceptable quantitative coronary angiographic result (Ͻ35% diameter stenosis) identified a subset of patients after single-vessel balloon angioplasty in whom there was a 16% angiographic restenosis rate and a 16% target lesion revascularization rate at the 6-month follow-up. Using FFR after angioplasty without stenting, Bech et al 47 found that when a FFRϾ0.9 was achieved, repeat interventions at 6, 12, and 24 months were 12%, 12%, and 15%, respectively, compared with patients who had a FFRՅ0.9 after angioplasty, with restenosis rates of 24%, 28%, and 30% at 2 years.
A physiologically-guided angioplasty approach is being prospectively evaluated in 3 multicenter trials: DESTINI-CFR (Doppler Endpoint Stent International Investigation of Coronary Flow Reserve), DEBATE II, and FROST (French Optimal Stent Trial. These studies will confirm whether a provisional, physiologically-guided approach will produce clinical outcomes equivalent to a mandatory or primary stent approach without the adverse effects of stenting.
Preliminary data from studies in Ͼ1000 patients indicate that although crossover to stenting was required in Ϸ40% to 50% of patients, the major adverse in-hospital and 6-month clinical cardiac event rates were similar in both provisional and primary stent strategies. The physiologically-guided approach to balloon angioplasty, although clinically supported and economically attractive, seems limited by operator preferences and advances in stent technology that have reduced stent-related complications and restenosis.
Emerging Developments in Catheterization
Laboratory-Based Coronary Physiology
The coronary physiology after acute myocardial infarction and reperfusion strongly influences clinical outcomes. 48 In patients with acute infarction, the microcirculatory responses to pharmacological and mechanical interventions that release or remove thrombus or particulate matter can be quantitated in physiological terms and, using FFR, discriminated from epicardial flow impairment.
For example, Claeys et al 49 reported that for similar angiographic stenoses, the CVR measured 13Ϯ7 days after acute myocardial infarction in 36 patients was lower both before and after angioplasty compared with the 38 patients without myocardial infarctions (1.22Ϯ0.26 versus 1.50Ϯ0.45 and 1.72Ϯ0.43 versus 2.21Ϯ0.74, respectively). Although CVR increased after angioplasty in both patient groups, a persistently impaired CVR was present in 80% of patients with acute myocardial infarctions and in only 44% of patients without myocardial infarctions, which suggests that CVR was related more to conduit narrowing than myocardial viability and that increasing the residual lumen by stenting may improve myocardial recovery.
Similarly, Neumann et al 50 examined acute and 14-day coronary flow and left ventricular wall motion in 102 patients with acute myocardial infarction who received abciximab and in 98 patients who received standard care with heparin. With similar degrees of residual stenosis, the change in peak (but not resting) flow velocity was greater (PϽ0.024) and wall motion index improved more (PϽ0.007) in the patients receiving abciximab. Coronary physiological responses correlated with left ventricular functional recovery, which suggests that mechanisms involving microvascular perfusion may identify new therapeutic avenues in these patients.
Summary
Recent advances in our understanding of human coronary circulation and clinically-validated physiological relationships to ischemic stress testing in patients have enhanced the conceptual applications of and overcome most technical limitations surrounding the usefulness of in-laboratory coronary physiological measurements to facilitate clinical decisions to treat or defer intervention. Although current clinical practice favors primary stenting, when considering strategies for optimal balloon angioplasty compared with obligatory stenting, multicenter preliminary reports indicate that a physiologically-guided approach can identify Ϸ50% of patients who will have equivalent clinical outcomes without the additional cost of stents and the potential for in-stent restenosis.
The practical application of physiological concepts in patients strongly complements coronary lumenology 51 and has important clinical and economic implications for the care of patients with coronary artery disease.
